US Stock MarketDetailed Quotes
LADX LadRx
- 2.120000
- +0.020000+0.95%
15min DelayClose Apr 19 16:00 ET
1.05MMarket Cap3.12P/E (TTM)
2.120000High2.100000Low829Volume2.100000Open2.100000Pre Close1.75KTurnover0.17%Turnover Ratio3.12P/E (Static)495.09KShares1770.00000052wk High9.77P/B1.04MFloat Cap0.63020052wk Low--Dividend TTM490.08KShs Float16222500.000000Historical High--Div YieldTTM0.95%Amplitude0.630000Historical Low2.108000Avg Price1Lot Size
About LadRx Company
LadRx Corp. is a biopharmaceutical research and development company. It engages in the discovery, research, and clinical development of novel anti-cancer drug candidates that employ novel technologies targeting chemotherapeutic drugs to solid tumors and reduce off-target toxicities. The company was founded in 1985 and is headquartered in Los Angeles, CA.
Company Profile
SymbolLADX
Company NameLadRx
Founded1985
MarketPink Market
Employees2
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address11726 San Vicente Boulevard,Suite 650
CityLos Angeles
ProvinceCalifornia
CountryUnited States of America
Zip Code90049
Phone1-310-826-5648
Websitehttp://www.ladrxcorp.com
Company Executives
- Name
- Position
- Salary
- Stephen Snowdy
- Chief Executive Officer
- --
- John Y. Caloz
- Chief Financial Officer, Chief Accounting Officer, Treasurer and Senior Vice President
- --
- Dr. Jennifer K. Simpson
- Independent Chairman of the Board
- --
- Joel Caldwell
- Lead Independent Director
- --
- Cary Claiborne
- Independent Director
- --
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg